Downstream of its receptor, effects of IL-22-signaling are mediated by activation of signal transducer and activator of transcription (STAT) 3, although STAT1 and STAT5 can be equally phosphorylated in hepatoma cells upon IL-22-stimulation [18]. This evidence concerns the gene IL22 and hepatocellular carcinoma.